Adipose Tissue and Metabolic Disease

A special issue of Cells (ISSN 2073-4409).

Deadline for manuscript submissions: closed (10 October 2023) | Viewed by 2284

Special Issue Editors


E-Mail Website
Guest Editor
Department of Hepatology and Gastroenterology, Charité-University Medicine Berlin, 13353 Berlin, Germany
Interests: diabetes type 2; endocrine pancreas; obesity; appetite regulation

E-Mail Website
Guest Editor
Department of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland
Interests: diabetes; obesity; fat tissue; pancreas; liver; muscle; metabolic syndrome; cell biology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland
Interests: adipose tissue; cell biology; diabetes; metabolism; obesity
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleague,

Adipose tissue plays a crucial role in energy homeostasis, storing excess energy in the form of lipids and releasing it when needed. However, in obesity, the expansion of adipose tissue can lead to metabolic dysfunction and inflammation. Hormones play a critical role in regulating adipose tissue development, function, and metabolism. Adipose tissue is the primary target of insulin, which promotes glucose uptake and lipid storage. Leptin, one of the best-known adipocyte-released hormone, controls energy balance and appetite, suppressing food intake and increasing energy expenditure. Adiponectin, another adipokine, has insulin-sensitizing and anti-inflammatory effects, protecting against metabolic disorders. Moreover, sex hormones such as estrogen and testosterone influence adipose tissue distribution and metabolism. Dysregulation of hormone signaling in obesity disrupts the fine-tuned feedback mechanisms that maintain energy balance, leading to excessive fat storage, insulin resistance, and inflammation. Understanding the complex interactions between hormones and adipose tissue in the context of obesity is crucial for developing effective therapies to combat its associated health risks, such as type 2 diabetes, cardiovascular disease, and cancer. Here, we review the current literature on adipose tissue regulation and obesity, including the molecular mechanisms that control adipogenesis, lipogenesis, lipolysis, and adipose tissue inflammation in both animals and humans. The role of adipokines, hormones secreted by adipose tissue, in regulating energy metabolism and inflammation is discussed, as well as the contribution of genetics and epigenetics in adipose tissue regulation. Additionally, the potential therapeutic strategies for obesity treatment based on adipose tissue regulation are also examined. In summary, we highlight the importance of future research in adipose tissue regulation and obesity to address the current health crisis.

Prof. Dr. Mathias Z. Strowski
Dr. Paweł A. A. Kołodziejski
Dr. Marek Skrzypski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adipose tissues
  • preadipocytes
  • adipocyte differentiation
  • adipokines
  • cytokines
  • obesity
  • fat tissue inflammation
  • anti-obesity agents
  • insulin resistance
  • insulin sensitivity
  • food intake

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

23 pages, 3599 KiB  
Article
Effect of Vitamin D3 on Chemerin and Adiponectin Levels in Uterus of Polycystic Ovary Syndrome Rats
by Karolina Pich, Jesika Rajewska, Kinga Kamińska, Marcelina Tchurzyk, Agata Szlaga, Patryk Sambak, Anna Błasiak, Małgorzata Grzesiak and Agnieszka Rak
Cells 2023, 12(16), 2026; https://doi.org/10.3390/cells12162026 - 08 Aug 2023
Cited by 1 | Viewed by 1846
Abstract
Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder with disrupted uterus structure and function. A positive effect of vitamin D3 (VD3) in female reproduction was observed. Chemerin (RARRES2) and adiponectin (ADIPOQ) are the main adipokines whose levels are altered [...] Read more.
Background: Polycystic ovary syndrome (PCOS) is an endocrine disorder with disrupted uterus structure and function. A positive effect of vitamin D3 (VD3) in female reproduction was observed. Chemerin (RARRES2) and adiponectin (ADIPOQ) are the main adipokines whose levels are altered in PCOS patients. Therefore, the aim of this study was to investigate the impact of VD3 supplementation on RARRES2 and ADIPOQ levels in the uterus of PCOS rats. Methods: We analyzed the plasma levels and uterine transcript and protein expression of RARRES2 and ADIPOQ and their receptors (CCRL2, CMKLR1, GPR1, and ADIPOR1 and ADIPOR2, respectively) in rats with letrozole-induced PCOS. Results: In control animals, VD3 did not change plasma levels of both adipokines, while in PCOS rats supplemented with VD3, they returned to control levels. The expression of RARRES2 and all investigated receptors increased in the uterus of VD3-treated rats; however, the levels of Rarres2 and Gpr1 genes remained unchanged. VD3 supplementation decreased RARRES2, CMKLR1, and GPR1 but increased CCRL2 level to the control value. In the uterus of VD3-treated rats, the transcript and protein levels of ADIPOQ and both receptors ADIPOR1 increased. At the same time, VD3 supplementation induced an increase in Adipoq, Adipor1, and Adipor2 gene expression and restored protein levels to control level values. Conclusions: our findings indicate a new mechanism of VD3 action in the uterine physiology of PCOS rats. Full article
(This article belongs to the Special Issue Adipose Tissue and Metabolic Disease)
Show Figures

Figure 1

Back to TopTop